PHAXIAM Therapeutics SA (STU:2E40)
€ 1.516 0 (0%) Market Cap: 16.39 Mil Enterprise Value: -5.41 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 38/100

Q3 2021 Erytech Pharma SA Earnings Call Transcript

Nov 16, 2021 / 01:30PM GMT
Release Date Price: €19.61 (-3.36%)
Operator

Good day, and thank you for standing by. Welcome to the ERYTECH Pharma third-quarter 2021 business update conference call. (Operator Instructions) Please be advised, today's conference may be recorded. (Operator Instructions)

I'd now like to hand the conference over to your host today, Gil Beyen, Chief Executive Officer. Please go ahead.

Gil Beyen
ERYTECH Pharma S.A. - CEO

Thank you. Good afternoon. Good morning. (Spoken in French) Thank you for joining us for our update call to discuss the key highlights and financials for the first nine months of this year.

We issued our Q3 business and financial press release yesterday evening. You should be able to find it together with the webcast presentation on the Investors section of our website.

Joining me on this call here today are Dr. Iman El-Hariry, our Chief Medical Officer; and Eric Soyer, our Chief Financial and Chief Operating Officer.

Before starting, I would like to draw your attention to the disclaimer on Slide 2 to remind you that today's call includes forward

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot